Recipient
vadiMAPDepartment
National Research Council CanadaAmount
$78.9K
Province
QCType
C
Agreement Number
1021725
Purpose
The R&D project involves making the most of all the firm’s accumulated data, which is not yet being exploited to its full potential. In particular, the integration of artificial intelligence tools into the entire process will: 1) Accelerate and increase the precision of the automated prescription process; 2) Reduce the overall infrastructure costs of the firm’s platforms; 3) Develop innovative new functionalities to constantly accentuate the break with traditional engineering.
vadiMAP × National Research Council Canada
3 grants totalling $277.8K
Industrial Research Assistance Program – Contributions to Firms
1,000 grants totalling $111.3M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Providence Therapeutics Holdings Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Laurent Thérapeutiques | $10.0M | Industrial Research Assistance Program –... |
| Laurent Thérapeutiques | $10.0M | Industrial Research Assistance Program –... |